Clinical trial

Effect of Renal Denervation on Stress, Hypertension and Anxiety Management

NCT05438446

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-10-18

PhasePHASE2

Study timeline

Study start (actual)2021-10-18Date precision: day

Registry last updated2026-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension Arterialunresolved

Anxietyunresolved

Stressunresolved

Interventions

Endovascular ultrasound renal denervation (Paradise renal denervation system, ReCor, CA, USA) (RDN)PROCEDURE

Sponsors & collaborators

Hippocration General Hospitallead sponsor

ReCor Medical, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05438446 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.